Showing results (771-780 of 1,107) with videos related to

Sort By:
Pageof 111
Diabetes Care|August 1, 1990
Comparison of albumin excretion rate obtained with different times of collectionT B Wiegmann, A M Chonko, M J Barnard, et al.
ACS Infectious Diseases|February 3, 2021
Immunogenicity Assessment of Cell Wall Carbohydrates of Group A Streptococcus via Self-Adjuvanted Glyco-lipopeptidesFarjana Khatun, Charles C Dai, Tania Rivera-Hernandez, et al.
European Urology Oncology|May 18, 2019
Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical ProstatectomyMatthew Mossanen, Kenneth G Nepple, Robert L Grubb, et al.
The Journal of Biological Chemistry|September 6, 2000
Disruption of a single copy of the SERCA2 gene results in altered Ca2+ homeostasis and cardiomyocyte functionY Ji, M J Lalli, G J Babu, et al.
Investigational New Drugs|June 20, 2012
A phase IB trial of 24-hour intravenous PX-12, a thioredoxin-1 inhibitor, in patients with advanced gastrointestinal cancersA F Baker, K N Adab, N Raghunand, et al.
Urology|February 8, 2011
Neoadjuvant systemic therapy or early cystectomy? Single-center analysis of outcomes after therapy for patients with clinically localized micropapillary urothelial carcinoma of the bladderIslam A Ghoneim, Ranko Miocinovic, Andrew J Stephenson, et al.
Molecular Pharmacology|July 3, 2004
Discovery and characterization of novel small molecule inhibitors of human Cdc25B dual specificity phosphataseMarni Brisson, Theresa Nguyen, Andreas Vogt, et al.
Clinical Therapeutics|July 28, 2018
Real-world Clinical Characteristics, Treatment Patterns, and Exacerbations in US Patients With Asthma Newly Treated With OmalizumabXuehua Ke, Abhishek Kavati, Debra Wertz, et al.
Pilot and Feasibility Studies|September 2, 2025
A cluster randomised feasibility trial assessing an interactive film intervention to improve wellbeing of young people in school settings in the North of EnglandF Christie-de Jong, E Walker, H Corlett, et al.
Archives of Disease in Childhood|November 13, 2003
Systemic exposure, tolerability, and efficacy of pimecrolimus cream 1% in atopic dermatitis patientsB R Allen, M Lakhanpaul, A Morris, et al.
Pageof 111